We extract cannabinoids from plant source material using industrial-scale supercritical CO2 systems, allowing precise control over extraction selectivity, yield, and impurity profiles. This approach enables the efficient recovery of cannabinoids while preserving product integrity and supporting downstream purification.
We also offer dedicated extraction routes for off-spec and non-standard biomass, converting material that would otherwise fall outside finished-product specifications into pharmaceutical-grade cannabinoid extracts.
RX Extraction provides GMP extraction of cannabinoids from plant source material, including medical cannabis biomass that is not suitable for finished medicinal product presentation, where appropriate and authorised.
This includes material that does not meet finished product specifications for reasons such as physical form, appearance, or downstream presentation requirements, but remains suitable for active substance manufacture when assessed and processed within a GMP framework.
Through controlled extraction, purification and crystallisation, such material can be converted into defined cannabinoid active pharmaceutical ingredients (APIs), supporting efficient use of resources while maintaining pharmaceutical quality standards.
